Fundamental advances in genetic sequencing technologies were stimulated by the human genome project and are now in turn transforming genome science and medicine. Yet the promise of genomic medicine remains limited by the lack of definitive sources of information about the genetic contributions to disease. Although many groups are attempting to address this gap individually, such efforts will ultimately fall shor if they remain disconnected. The Clinically Relevant Variants Resource represents a collaborative effort of the genetics community to establish an evidence-based resource for the assessment of the clinical relevance of genes and variants. This knowledge base is critical for confident, efficient analysis and interpretation of genome-scale sequence data. The objective is to provide a publicly available consensus summary of the evidence from the medical literature, basic science researchers, and clinical laboratories regarding the genes and variants that are implicated in human health and disease. Dedicated portals will be provided for researchers, clinical laboratories, physicians, patients, and electronic health records to ensure that the resource is widely accessible. The consortium of investigators will accomplish this objective by pursuing five specific aims: 1) developing a semi-quantitative methodology for assessing the clinical actionability of gene- phenotype pairs, which will allow stakeholder groups to provide guidance on the reporting and use of such genetic results; 2) establishing a standardized process for evaluating whether variants are benign, related to disease, or of uncertain significance; 3) deploying an informatics infrastructure to support the activities of the consortiu by aggregating information from disparate sources and presenting it for human evaluation; 4) assembling clinical domain-specific working groups to systematically evaluate the genes (and the variants in those genes) that are clinically relevant; and 5) ensuring the interoperability of he resource with electronic medical record systems. The approach innovates by developing novel approaches for the assessment of genes and variants that are robust and reproducible, and by establishing a distributed informatics system for aggregating and displaying information, with mechanisms for updating and reanalysis. The proposal is forward-thinking in that attention will be paid to ensuring the interoperability of the resource with diverse end-users, including electronic health records. The proposed resource project is significant because it will provide freely available expert curation of the human genome across a substantial number of clinical domains, with a transparent and evidence-based approach.

Public Health Relevance

The Clinically Relevant Variants Resource will make a fundamental contribution to the public health by providing a centralized, publicly accessible repository of information about human genetic variation and its relationship with health and disease. The resource will facilitate the clinical interpretation of genome-scale sequencing tests, thus overcoming a significant barrier to their implementation in clinical medicine. Thus, the proposed resource is relevant to the NHGRI's path towards an era of genomic medicine.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01HG007437-03S1
Application #
9117002
Study Section
Special Emphasis Panel (ZHG1 (M2))
Program Officer
Ramos, Erin
Project Start
2013-09-23
Project End
2017-07-31
Budget Start
2015-08-01
Budget End
2016-07-31
Support Year
3
Fiscal Year
2015
Total Cost
$165,625
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Genetics
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Webber, Elizabeth M; Hunter, Jessica Ezzell; Biesecker, Leslie G et al. (2018) Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group. Hum Mutat 39:1677-1685
Pawliczek, Piotr; Patel, Ronak Y; Ashmore, Lillian R et al. (2018) ClinGen Allele Registry links information about genetic variants. Hum Mutat 39:1690-1701
Iacocca, Michael A; Chora, Joana R; CarriƩ, Alain et al. (2018) ClinVar database of global familial hypercholesterolemia-associated DNA variants. Hum Mutat 39:1631-1640
Hosseini, S Mohsen; Kim, Raymond; Udupa, Sharmila et al. (2018) Reappraisal of Reported Genes for Sudden Arrhythmic Death. Circulation 138:1195-1205
Danos, Arpad M; Ritter, Deborah I; Wagner, Alex H et al. (2018) Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards. Hum Mutat 39:1721-1732
Abou Tayoun, Ahmad N; Pesaran, Tina; DiStefano, Marina T et al. (2018) Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum Mutat 39:1517-1524
Savatt, Juliann M; Azzariti, Danielle R; Faucett, W Andrew et al. (2018) ClinGen's GenomeConnect registry enables patient-centered data sharing. Hum Mutat 39:1668-1676
Mester, Jessica L; Ghosh, Rajarshi; Pesaran, Tina et al. (2018) Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel. Hum Mutat 39:1581-1592
Dolman, Lena; Page, Angela; Babb, Lawrence et al. (2018) ClinGen advancing genomic data-sharing standards as a GA4GH driver project. Hum Mutat 39:1686-1689
Zastrow, Diane B; Baudet, Heather; Shen, Wei et al. (2018) Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): The ClinGen IEM Working Group and the Phenylalanine Hydroxylase Gene. Hum Mutat 39:1569-1580

Showing the most recent 10 out of 43 publications